Cyp2c18 is also thought to be involved in hepatic arachidonic acid and linoleic acid metabolism [28] and has been shown to be up-regulated in other models of NAFLD [29]. Here, CYP2C18 is linked to metabolic dysfunction-associated steatotic liver disease.